Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-007974
Filing Date
2019-02-14
Accepted
2019-02-14 14:04:09
Documents
62
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv512474_10q.htm 10-Q 430549
2 EXHIBIT 10.1 tv512474_ex10-1.htm EX-10.1 11841
3 EXHIBIT 10.2 tv512474_ex10-2.htm EX-10.2 23193
4 EXHIBIT 10.3 tv512474_ex10-3.htm EX-10.3 91436
5 EXHIBIT 31.1 tv512474_ex31-1.htm EX-31.1 11093
6 EXHIBIT 31.2 tv512474_ex31-2.htm EX-31.2 11093
7 EXHIBIT 32.1 tv512474_ex32-1.htm EX-32.1 5075
8 EXHIBIT 32.2 tv512474_ex32-2.htm EX-32.2 5111
  Complete submission text file 0001144204-19-007974.txt   6596679

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT rzlt-20181231.xml EX-101.INS 2025751
10 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20181231.xsd EX-101.SCH 42237
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rzlt-20181231_cal.xml EX-101.CAL 38321
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rzlt-20181231_def.xml EX-101.DEF 309534
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20181231_lab.xml EX-101.LAB 320510
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20181231_pre.xml EX-101.PRE 338280
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54495 | Film No.: 19604407
SIC: 2834 Pharmaceutical Preparations